CAPLIPOINT - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.9
| Stock Code | CAPLIPOINT | Market Cap | 14,521 Cr. | Current Price | 1,905 ₹ | High / Low | 2,397 ₹ |
| Stock P/E | 41.5 | Book Value | 243 ₹ | Dividend Yield | 0.31 % | ROCE | 28.6 % |
| ROE | 22.0 % | Face Value | 2.00 ₹ | DMA 50 | 1,859 ₹ | DMA 200 | 1,960 ₹ |
| Chg in FII Hold | 0.07 % | Chg in DII Hold | -0.05 % | PAT Qtr | 103 Cr. | PAT Prev Qtr | 85.9 Cr. |
| RSI | 61.4 | MACD | -9.44 | Volume | 70,687 | Avg Vol 1Wk | 55,153 |
| Low price | 1,551 ₹ | High price | 2,397 ₹ | PEG Ratio | 1.89 | Debt to equity | 0.00 |
| 52w Index | 41.8 % | Qtr Profit Var | -2.98 % | EPS | 46.0 ₹ | Industry PE | 29.1 |
📊 Analysis: CAPLIPOINT shows moderate potential for intraday trading. RSI at 61.4 indicates slightly overbought conditions, while MACD at -9.44 signals short-term bearish divergence. Current price (1,905 ₹) is above the 50 DMA (1,859 ₹) but below the 200 DMA (1,960 ₹), suggesting mixed momentum. Volume (70,687) is higher than the weekly average (55,153), which supports intraday activity.
💰 Optimal Buy Price: Around 1,895–1,905 ₹ (near current levels with 50 DMA support).
📈 Profit-Taking Exit Levels: 1,930–1,950 ₹ (short-term resistance zone).
📉 Stop-Loss / Loss Protection: 1,880 ₹ (below intraday support).
⏱️ If Already Holding: Consider exiting if price fails to sustain above 1,900 ₹ with weakening momentum or if MACD continues bearish. If momentum strengthens, ride till 1,930–1,950 ₹ before booking profits.
Positive
- Strong ROCE at 28.6% and ROE at 22% indicate efficient capital usage.
- Debt-free balance sheet (Debt-to-equity 0.00) adds financial stability.
- EPS of 46.0 ₹ supports valuation strength.
- Volume higher than weekly average indicates active participation today.
Limitation
- High P/E ratio of 41.5 compared to industry PE of 29.1 suggests overvaluation.
- MACD negative (-9.44) signals short-term bearishness.
- Quarterly profit variation (-2.98%) shows slight decline in earnings momentum.
- 52-week index at 41.8% indicates stock is far from its peak levels.
Company Negative News
- No major negative news reported recently, but earnings slowdown is a concern.
Company Positive News
- Quarterly PAT at 103 Cr. remains strong despite slight decline.
- Stable institutional interest with marginal FII increase (+0.07%).
Industry
- Industry PE at 29.1 vs stock PE at 41.5 indicates premium valuation.
- Pharmaceutical sector remains supported by global demand and healthcare focus.
Conclusion
⚡ CAPLIPOINT is a moderately cautious candidate for intraday trading today. Buy near 1,895–1,905 ₹ with profit targets at 1,930–1,950 ₹ and stop-loss at 1,880 ₹. If already holding, monitor MACD and RSI closely and exit near resistance levels. Strong fundamentals and debt-free status support the stock, but high valuation and short-term bearish signals limit upside potential.